ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

Evidence Reported That Silica Increase Risk Of Cancer

September 7, 1984

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts

November 1, 1991

An Angel In heaven – Or How Rejected Grants Do and Don’t Get Reviewed

May 3, 1974